GE HealthCare Technologies Inc. is on the rise following a significant acquisition announcement.
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is gaining today, with shares climbing 1.66% to close at CA$65.36. This positive momentum comes after the company's announcement of its acquisition of Sofie Biosciences for $945 million, a strategic move aimed at expanding its presence in the growing radiopharmaceutical market.
Investor takeaway: Investors are responding favorably to GE HealthCare's acquisition of Sofie Biosciences, viewing it as a strong step toward enhancing its capabilities in the lucrative PET radiopharmaceutical sector.
Advertisement
GE HealthCare Technologies Inc.
GEHC.US
GEHC.US
GE HealthCare Technologies Inc.
WealthAwesomeMarket cap
$29.10B
P/E
14.7x
Div. yield
0.21%
Div. / share
$0.14
52W high
$89.64
52W low
$58.72
1W change
-3.62%
Beta
0.82
Analyst Price Targets
Based on 21 analysts covering GEHC · as of Sep 23, 2026
Wall Street analysts forecast GEHC stock price to rise 29.8% over the next 12 months.
Consensus
Buy4.33 / 5.00
Avg. Target
C$83.05
+29.8% Upside
Previously C$82.50 on Sep 17, 2026
Current Price
C$63.98
Last close
Analyst Breakdown (21 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GEHC's historical volatility
30-Day Vol
18.1%
Annualized
90-Day Vol
35.8%
Annualized
Trend (90d)
-4.3%
Annualized drift
90d Mean
C$63.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$63.65 | C$59.79 – C$67.76 |
| 60 trading days | C$63.32 | C$57.96 – C$69.18 |
| 90 trading days | C$63.00 | C$56.53 – C$70.21 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
1.66% Increase in Stock Price
GE HealthCare's stock has risen by 1.66% today, reflecting investor optimism following its strategic acquisition announcement.
Bull case
The acquisition of Sofie Biosciences positions GE HealthCare to enter a rapidly growing market. This move could increase revenue streams and enhance its product offerings in precision medicine.
Bear case
While the acquisition is promising, there are concerns about integration challenges and the significant cash outlay, which could impact GE HealthCare's short-term financial flexibility.
Advertisement
Strategic Acquisition to Enhance Market Position
GE HealthCare's decision to acquire Sofie Biosciences marks a significant investment in the radiopharmaceutical sector. This acquisition is expected to enhance GE HealthCare's capabilities in providing cutting-edge imaging solutions and improve patient access to essential diagnostic tools. The transaction is anticipated to close in the first half of 2027, pending regulatory approvals.
Investor Sentiment and Market Response
The market has reacted positively to the news of the acquisition, with GE HealthCare's stock price reflecting a 1.66% increase. Investors are optimistic that this strategic move will bolster the company's growth trajectory and strengthen its competitive edge in the healthcare technology landscape. Analysts believe that expanding into the PET radiopharmaceutical market could lead to substantial revenue growth.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
